So excited to share this Cencora white paper titled "Unraveling Payer Trends" (authored and led by Shaila Yoshida) as a consolidated resource of market research we've conducted over the past ~1 year. This includes >20 posters on value assessments, management of cell and gene therapies, opinions on PIE, use of AI in lit reviews, early access programs in the EU and more! Very cool to see findings from numerous research projects completed by my colleagues and I!! ▶ Follow this link to access the report: https://lnkd.in/ezeeDUPh
Kyle A. Noonan, PharmD, MS’ Post
More Relevant Posts
-
We’re just TWO days away! 👥 Meet the experts behind our webinar. Join us July 25th at 2pm ET for "Navigating the Future of Cell and Gene Therapy: Financial Landscape & Market Dynamics by Disease Type." This is your last chance to register, don’t miss out on exclusive insights into market trends and investment opportunities. Register now! https://hubs.la/Q02HGTlg0 #CellandGeneTherapy #CGT #Kalorama #FinancialTrends #MarketDynamics #Webinar #RegisterNow
To view or add a comment, sign in
-
-
Drew Wilkins To my network of benefits professionals -- especially organization benefits managers, directors, VPs of TR, and CHROs! Cell and Gene Therapies are the next big issue to tackle. Please take this quick survey to let us know your thoughts and perspectives. https://lnkd.in/e4fS3eP7
Calling all employee benefit leaders and consultants, the Integrated Benefits Institute (IBI) would like to understand your perspectives on cell and gene therapies and information interests related to clinical innovation and costs. Your feedback is critical and the survey will take less than five minutes! https://lnkd.in/e4fS3eP7 The survey is for all individuals no matter their depth of cell and gene therapy knowledge or experience. Aggregate study findings will be shared broadly and help inform the development of future materials. #humanresources #employeewellbeing #celltherapy #genetherapy
To view or add a comment, sign in
-
-
Calling all employee benefit leaders and consultants, the Integrated Benefits Institute (IBI) would like to understand your perspectives on cell and gene therapies and information interests related to clinical innovation and costs. Your feedback is critical and the survey will take less than five minutes! https://lnkd.in/e4fS3eP7 The survey is for all individuals no matter their depth of cell and gene therapy knowledge or experience. Aggregate study findings will be shared broadly and help inform the development of future materials. #humanresources #employeewellbeing #celltherapy #genetherapy
To view or add a comment, sign in
-
-
✔️ Looks like it was a great week in Liverpool from the feedback - Lots of change since I last attended the BioIndustry Association (BIA) BioprocessUK at the Manchester Midland, just before I moved to India. ⏳ The big subjects then were protein therapeutic processing and the importance of yield, stability, and aggregation. The focus has shifted since then to Gene & Cell Therapies, as you might expect - how to process and manufacture these innovative medicines more efficiently to maximise patient-benefit. 🧬 Whether it be mAbs or Gene Therapies, or any of the other cutting-edge modalities being developed to improve health, Malvern Panalytical Pharmaceuticals has the biophysical tech and knowledge to de-risk and speed up your development processes. For more, please see here: https://lnkd.in/gj57ZxMi #CGT #BioprocessUK #mAb #Biologics
This week at the BioIndustry Association (BIA)'s bioProcessUK 2024 event, Stephen Ward, Chief Technology Officer at the CGT Catapult, joined an panel discussion on #sustainable manufacturing. The panel provided expert insights into the future of cell and gene therapy and the need for manufacturing to align with commercial goals. Learn more about upcoming events we are involved in: https://ow.ly/6KH950Ub5Sf #bioProcessUK #BIA #CellandGene
To view or add a comment, sign in
-
-
This week at the BioIndustry Association (BIA)'s bioProcessUK 2024 event, Stephen Ward, Chief Technology Officer at the CGT Catapult, joined an panel discussion on #sustainable manufacturing. The panel provided expert insights into the future of cell and gene therapy and the need for manufacturing to align with commercial goals. Learn more about upcoming events we are involved in: https://ow.ly/6KH950Ub5Sf #bioProcessUK #BIA #CellandGene
To view or add a comment, sign in
-
-
Headed to #ASGCT2024? Meet the Form Bio team at booth #729 to learn how AI can optimize gene therapy construct designs for faster delivery to market with a higher probability of success. Pre-book a scientific consultation and learn more about our conference program, including workshops, symposia, and abstract presentations at our event page: https://hubs.li/Q02t5djn0 #cellandgenetherapy #genetherapy #AAV #AI
To view or add a comment, sign in
-
-
Interested in learning how the #AdvancedTherapies industry can enhance today's manufacturing practices to establish fully automated, digitally integrated processes? ➡️ https://buff.ly/3BthKPL Daniel Gibson, Head of Collaborations at the Cell and Gene Therapy Catapult, highlights this and more in his key takeaways from Phacilitate's recent Advanced Therapies Europe event. Read the blog ☝️ #CellTherapy #GeneTherapy #ATMPs
To view or add a comment, sign in
-
-
Attn: Benefits folks! The number of FDA approved cell & gene therapies is expected to more than quadruple by 2032 (85 new gene therapies across more than 12 therapeutic areas). What info do you need to best inform your future benefit decisions? Share your perspectives in Integrated Benefits Institute's 5-minute study below 👇
Calling all employee benefit leaders and consultants, the Integrated Benefits Institute (IBI) would like to understand your perspectives on cell and gene therapies and information interests related to clinical innovation and costs. Your feedback is critical and the survey will take less than five minutes! https://lnkd.in/e4fS3eP7 The survey is for all individuals no matter their depth of cell and gene therapy knowledge or experience. Aggregate study findings will be shared broadly and help inform the development of future materials. #humanresources #employeewellbeing #celltherapy #genetherapy
To view or add a comment, sign in
-
-
Tiny tools for big breakthroughs! Bio-Rad Laboratories’s VeriCheck ddPCR Kits are here to supercharge AAV gene therapy research with precise, reliable results. Why settle for "meh" accuracy when you can have ddPCR precision? These kits simplify workflows while giving you the data confidence to go from "What if?" to "Look what we did!" Ready to expand your AAV research horizons? Check out the details: https://bit.ly/4jC2MbV
To view or add a comment, sign in
-
-
You are invited to the Biophysical Summit hosted by Applied Photophysics and KBI Biopharma! 🏔 Join us for an interactive workshop to discuss best practices for Biophysical Characterisation. Hear from recognized experts about critical regulatory expectations and the best practices for the characterisation of higher order structure of molecules. This summit will highlight some of the latest analytical techniques for developing and characterizing protein and gene therapies. Come with your questions and learn how companies tackle the characterization of novel modalities. Register here: https://bit.ly/3TYGnt9 #BiophysicalSummit #KBI #AppliedPhotophysics #Biophysics
To view or add a comment, sign in